Related Experiment Video
Updated: May 12, 2026
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
MicroRNAs as Potential Biomarkers and Therapeutic Targets in Ischemic Stroke from the Perspective of Inflammation
Nai-He Chen1, Jia-Xin Ren1, Guang-Jian Li1
1Department of Neurology, The First Hospital of Jilin University, Changchun, 130021, China.
Abstract:
Ischemic stroke, triggered by the interruption of cerebral blood flow, initiates a complex inflammatory process involving both brain-resident and peripheral immune cells. Microglia, the primary brain-resident immune cells of high heterogeneity, regulate central nervous system inflammation upon activation. Activated microglia are commonly classified into two predominant phenotypes (pro-inflammatory M1 and anti-inflammatory M2), which exert dual effects through the secretion of distinct cytokine profiles. Peripheral immune cells, including monocytes, macrophages, and neutrophils, contribute to stroke pathogenesis and progression via diverse inflammatory mechanisms. Multiple microRNAs regulate the inflammatory dynamics of ischemic stroke across all phases by modulating both brain-resident and peripheral immune cells. MicroRNAs play a pivotal role in the activation and polarization of microglia, as well as cytokine release. Furthermore, microRNAs modulate the activation and extravasation processes of peripheral leukocytes by enhancing or attenuating signaling pathways. These mechanisms suggest that microRNA alterations could be biomarkers for predicting, diagnosing, and prognosticating ischemic stroke. Additionally, microRNA modulation offers potential as a therapeutic strategy for the treatment of ischemic stroke.
Insights
MicroRNAs significantly influence immune responses in ischemic stroke by regulating microglia and peripheral immune cells. These microRNAs show promise as biomarkers and therapeutic targets for stroke treatment.
Area of Science:
- Neuroscience
- Immunology
- Molecular Biology
Background:
- Ischemic stroke involves complex inflammation with brain-resident microglia and peripheral immune cells.
- Microglia exhibit diverse phenotypes (M1/M2) influencing central nervous system inflammation via cytokine profiles.
- Peripheral immune cells like monocytes, macrophages, and neutrophils contribute to stroke pathogenesis.
Purpose of the Study:
- To investigate the role of microRNAs in regulating immune cell dynamics during ischemic stroke.
- To explore microRNAs as potential biomarkers for ischemic stroke prediction, diagnosis, and prognosis.
- To assess the therapeutic potential of microRNA modulation in ischemic stroke treatment.
Main Methods:
- Review of literature on microRNA involvement in immune cell activation and polarization in stroke.
- Analysis of microRNA-mediated regulation of microglia (M1/M2) and cytokine release.
- Examination of microRNA effects on peripheral leukocyte activation and extravasation.
Main Results:
- MicroRNAs critically regulate microglial activation, polarization, and cytokine secretion.
- MicroRNAs modulate peripheral immune cell activity and their infiltration into the brain.
- Alterations in microRNA levels correlate with stroke phases and immune responses.
Conclusions:
- MicroRNAs are key regulators of neuroinflammation in ischemic stroke.
- MicroRNA profiles may serve as valuable biomarkers for ischemic stroke.
- Targeting microRNAs presents a promising therapeutic avenue for ischemic stroke.
